Clinical Trial Update: Ideal Time of Oxytocin Infusion During Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial investigating optimal timing of oxytocin infusion during cesarean section; terminated with incomplete status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss During Surgical Procedures
• Cesarean Section Complications
• Postpartum Hemorrhage
• Pregnancy-related Conditions

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Loyola University | Conditions: Blood Loss, Surgical, Postpartum Hemorrhage | Phase 4 | Status: TERMINATED